Aurinia Pharmaceuticals Inc (AUPH) stock news · P/E 7.2, $1.03B cap
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
This AUPH news page leads with what Aurinia Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for AUPH yet. We will not pad this page with generic market recap.
Latest reported AUPH revenue for 2026-06-30 was $83.2M. Net income was $37.4M. Revenue was up 7.1% from 2026-03-31 to 2026-06-30. AUPH currently screens at market cap $1.03B and trailing P/E 7.2.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the AUPH stock page; for the tape open the quote page.
AUPH stock news FAQ
What are AUPH's latest revenue and net income?
Latest cached Aurinia Pharmaceuticals Inc (AUPH) revenue for Jun 30, 2026 was $83.2M. Net income was $37.4M. Statements: https://lician.com/financials/auph
How did AUPH revenue change from the prior cached period?
Cached Aurinia Pharmaceuticals Inc (AUPH) revenue was up 7.1% from $77.7M (Mar 31, 2026) to $83.2M (Jun 30, 2026). Statements: https://lician.com/financials/auph
What is AUPH's P/E ratio?
Aurinia Pharmaceuticals Inc (AUPH) trailing P/E is 7.21 on the latest cached fundamentals snapshot.
What is AUPH's market cap?
Aurinia Pharmaceuticals Inc (AUPH) market cap is $1.03B on the latest cached fundamentals snapshot.
What kind of company is AUPH?
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Where is AUPH stock news listed?
Cached stock news for Aurinia Pharmaceuticals Inc (AUPH) is listed at https://lician.com/news/auph. Filings: https://lician.com/sec/auph
Not investment advice.